Stay updated on Cabozantinib for Metastatic Pheochromocytomas Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link.
    Difference
    0.2%
    Check dated 2025-09-14T00:09:29.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T21:07:54.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with relevant publications related to cabozantinib and a new version revision. Several previous location details and drug information have been removed.
    Difference
    4%
    Check dated 2025-08-30T15:40:33.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T12:34:24.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T08:06:23.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The webpage has updated the study results for Cabozantinib S-malate in treating metastatic pheochromocytomas and paragangliomas, with new reporting dates and a revised study protocol. Additionally, previous results and details have been removed, indicating a shift in the study's timeline and focus.
    Difference
    14%
    Check dated 2025-08-02T04:15:39.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Metastatic Pheochromocytomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.